Risk Stratification of Nodal PTCL

CompletedOBSERVATIONAL
Enrollment

405

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2017

Conditions
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaAnaplastic Large Cell Lymphoma, ALK-negative
Trial Locations (1)

561-712

Chonbuk Nationla University Hospital, Jeonju

All Listed Sponsors
collaborator

Chonnam National University Hospital

OTHER

collaborator

Kyungpook National University Hospital

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Korea University Guro Hospital

OTHER

collaborator

Dong-A University Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Chungnam National University Hospital

OTHER

collaborator

Samsung Medical Center

OTHER

lead

Chonbuk National University Hospital

OTHER

NCT03040206 - Risk Stratification of Nodal PTCL | Biotech Hunter | Biotech Hunter